Halozyme Therapeutics, Inc. (HALO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 43.84 |
| Open | 44.08 |
| Bid | 43.12 x 400 |
| Ask | 43.17 x 400 |
| Day's Range | 43.12 - 44.21 |
| 52 Week Range | 31.86 - 45.00 |
| Volume | |
| Avg. Volume | 1,025,769 |
| Market Cap | 5.492B |
| Beta (5Y Monthly) | 1.26 |
| PE Ratio (TTM) | 17.90 |
| EPS (TTM) | 2.41 |
| Earnings Date | Aug 06, 2024 - Aug 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 51.78 |
Investor's Business DailyBiotech Stocks To Watch: Halozyme Actionable Now After Earnings-Fueled Breakout
Halozyme Therapeutics is among top biotech stocks to buy and watch, as the stock trades inside a buy zone following earnings.
Insider MonkeyHalozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript May 7, 2024 Halozyme Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. My name is [Perla] (ph), and I’ll be your conference operator today. […]
ZacksHalozyme's (HALO) Q1 Earnings Beat, Revenues Lag Estimates
Halozyme (HALO) reports mixed first-quarter 2024 earnings. The company maintains revenue guidance for 2024.
© 2024 Yahoo. All rights reserved.